Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
Conditions
- Unresectable Hepatocellular Carcinoma
Interventions
- DRUG: Atezolizumab
- DRUG: Bevacizumab
- RADIATION: Stereotactic body radiation therapy (SBRT)
Sponsor
Massachusetts General Hospital
Collaborators